[Cardiovascular risk factors prevalence among patients with dyslipidemia in Colombia]

Jorge E Machado-Alba1, Manuel E Machado-Duque

  • 1Grupo de investigación en fármacoepidemiología y farmacovigilancia, Universidad Tecnológica de Pereira, Pereira, Colombia.

Insights

Patients with dyslipidemia have a 14% 10-year cardiovascular event risk, with hypertension and diabetes being prevalent. Public health policies should target these risk factors to improve cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Context:

  • Dyslipidemia is a significant cardiovascular risk factor.
  • Understanding cardiovascular risk in dyslipidemic patients is crucial for preventative strategies.
  • Colombian healthcare system data provides a valuable population for study.

Purpose:

  • To determine the prevalence of cardiovascular risk factors.
  • To assess the 10-year risk of cardio-cerebrovascular events in dyslipidemic patients.
  • To inform public health policies in Colombia.

Summary:

  • A retrospective study analyzed 311 dyslipidemic patients in Colombia.
  • The mean 10-year cardiovascular event risk was 14%, with hypertension (93.2%) and diabetes (28.5%) being highly prevalent.
  • Mixed dyslipidemia was most common (46.6%).

Impact:

  • Identifies high cardiovascular risk in dyslipidemic patients.
  • Highlights the need for targeted interventions for hypertension and diabetes.
  • Provides data to support the development of public health policies for cardiovascular disease prevention.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...